Delivery Order SPE2DB22D3301-SPE2DB24FZ3UP

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $11,952.94 firm-fixed-price contract is for the supply of JANUMET XR 50-1,000 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of pharmaceutical and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of JANUMET XR 100-1,000 mg tablets. The contract has a ceiling value of $8,850.86 and is a firm fixed-price delivery order with a period of performance through September 30, 2024. The contract does not have any set-aside designations. As a supplier of pharmaceutical and medical products to numerous federal agencies and healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,936.63, is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of January 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of JANUMET XR 50-1,000 mg tablets in quantities of 1,000 per bottle. The award is a firm-fixed price contract with a ceiling value of $2,558.92 and an ultimate completion date of August 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,045.52, is for the delivery of Janumet XR 50-1,000 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $6,157.44 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of JANUMET XR 50-1,000 mg tablet (60s) and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite-delivery contracts by DLA and other federal agencies to provide a wide range of essential medical commodities, including prescription drugs, vaccines, and...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,166.95, is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 20, 2025. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,147.94, is for the supply of JANUMET XR 50-1,000 mg tablets over a period ending on April 1, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,874.29 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of JANUMET XR 50-1,000 mg tablets in 60-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Janumet XR 50-1,000 mg tablets. The contract has a ceiling value of $10,498.84 and an ultimate completion date of November 14, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ3UP
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET XR 50-1,000 MG tablets. The order, valued at $12,583.70, is a firm-fixed-price contract with an ultimate completion date of August 30, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, allowing them to efficiently provide a wide range of pharmaceutical and medical supplies to support military treatment programs and various government healthcare initiatives. This particular order is not associated with a set-aside program.

Generated 11/28/24, 9:38 AM